MDxHealth SA (NASDAQ: MDXH) had its price target lowered by analysts at Piper Sandler from $8.00 to $6.00. They now have an "overweight" rating on the stock.
MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings [Yahoo! Finance]
MDxHealth SA (NASDAQ: MDXH) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $7.00 price target on the stock.